Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06945120 | NOT YET RECRUITING | Smoking Cessation

ACT Lung Health Intervention: Phase Two
Sponsor:

Dana-Farber Cancer Institute

Information provided by (Responsible Party):

Mary E. Cooley, Phd

Brief Summary:

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Condition or disease

Smoking Cessation

Smoking Behaviors

Smoking, Tobacco

Smoking, Cigarette

Smoking (Tobacco) Addiction

Intervention/treatment

ACT Lung Health Intervention

Phase

NA

Detailed Description:

This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer. Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, questionnaires, and saliva tests. It is expected participation in this study will last about 6 months. About 128 participants are expected to take part in this research study. The National Cancer Institute is providing funding for this trial.

Study Type : INTERVENTIONAL
Estimated Enrollment : 128 participants
Masking : DOUBLE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Efficacy of an Asian Culture-tailored Lung Health (ACT) Intervention on Lung Cancer Screening and Smoking Cessation in Asian Americans
Actual Study Start Date : 2025-10
Estimated Primary Completion Date : 2026-02-10
Estimated Study Completion Date : 2026-08-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 50 Years to 80 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Self-identify as either Chinese or Korean
  • * Speak either Korean, Mandarin, or English
  • * Eligible for LDCT screening (50-80 years of age and 20- pack-year smoking history)
  • * Currently smoking (i.e., having smoked within the prior 30 days),
  • * Currently have active health insurance coverage and a primary healthcare provider and
  • * Have access to a video-call device with internet or wireless connection.
  • * Eastern Cooperative Oncology Group functional status \<2
  • * Live in the United States for the next 12 months
Exclusion Criteria
  • * Had LDCT screening done within the last 2 years.
  • * Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
  • * Previous history of lung cancer.
  • * We will not include any of the following special populations
    • * Adults unable to consent.
    • * Adults younger than 50 or older than 80 years
    • * Individuals who are not yet adults (infants, children, teenagers)
    • * Pregnant women
    • * Prisoners
ACT Lung Health Intervention: Phase Two

Location Details

NCT06945120

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

United States, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115